Pasithea Therapeutics Corp.
KTTA
$1.18
-$0.02-1.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.12M | 7.22M | 5.34M | 6.92M | 9.36M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.29M | 1.30M | 621.20K | 302.60K | 319.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 120.30K | 117.80K | 162.50K | 142.90K | 98.30K |
| Total Current Assets | 5.53M | 8.64M | 6.12M | 7.37M | 9.78M |
|
|
|||||
| Total Current Assets | 5.53M | 8.64M | 6.12M | 7.37M | 9.78M |
| Net Property, Plant & Equipment | -- | 113.60K | 117.50K | 122.30K | 127.10K |
| Long-term Investments | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
| Goodwill | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
| Total Other Intangibles | 6.84M | 7.00M | 7.15M | 7.31M | 7.47M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 13.63M | 17.01M | 14.66M | 16.06M | 18.64M |
|
|
|||||
| Total Accounts Payable | 1.34M | 1.58M | 1.33M | 1.12M | 660.40K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 39.30K | 155.50K | 269.00K | -- | -- |
| Total Other Current Liabilities | 39.30K | 155.50K | 269.00K | -- | -- |
| Total Current Liabilities | 1.38M | 1.74M | 1.59M | 1.12M | 660.40K |
|
|
|||||
| Total Current Liabilities | 1.38M | 1.74M | 1.59M | 1.12M | 660.40K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 46.90K | 93.70K | 85.30K | 162.20K | 163.60K |
| Total Liabilities | 1.42M | 1.83M | 1.68M | 1.28M | 824.00K |
|
|
|||||
| Common Stock & APIC | 72.09M | 72.04M | 66.12M | 64.37M | 64.25M |
| Retained Earnings | -59.90M | -56.86M | -53.15M | -49.58M | -46.41M |
| Treasury Stock & Other | 18.30K | 5.60K | -- | -7.20K | -35.30K |
| Total Common Equity | 12.21M | 15.18M | 12.98M | 14.78M | 17.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.21M | 15.18M | 12.98M | 14.78M | 17.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.21M | 15.18M | 12.98M | 14.78M | 17.81M |
|
|
|||||